OS THERAPIES INCORPORATED Conversion of Stock, Shares Issued
OS THERAPIES INCORPORATED (OSTX) reported Conversion of Stock, Shares Issued of 700.00 thousand shares for the 1-month period ending 2023-01-31, per its 10-Q filed 2024-05-20.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2026-03-31
- OS THERAPIES INCORPORATED conversion of stock, shares issued for fiscal 2020 was 200.00K shares.
| Period end | Conversion of Stock, Shares Issued 1 month | Conversion of Stock, Shares Issued 12 month | Conversion of Stock, Shares Issued 12 month as first filed |
|---|---|---|---|
| 2023-01-31 | 700.00K shares 10-Q · filed 2024-05-20 | ||
| 2020-12-31 | 200.00K shares 10-K · filed 2026-03-31 | 400.00K shares 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |